Navigation Links
AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Date:12/7/2009

-week screening period to confirm severity and stability of voiding symptoms based on the IPSS. Patients were then randomly allocated in a double-blind fashion to one of two cetrorelix dose groups or placebo, in a 2:1:1 ratio. Patients were administered cetrorelix by intra-muscular (IM) injection at Week 0, 2, 26 and 28 (for treatment Arm A, those in Arm B received IM injection at week 0, 2 and placebo injections both at Week 26 and 28). Patients in treatment Arm C received placebo injections at Week 0, 2, 26 and 28. All patients were followed up to Week 52. The study included 420 patients overall, 212, 106, and 102 patients allocated to Arm A, B, and C, respectively.

Conference Call

The Company will host a conference call and webcast to discuss these results later today, Monday, December 7, 2009 at 4:30 p.m., Eastern Time.

Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Investors" section, or by telephone using the following numbers: (outside Canada): 888-231-8191, (Canada): 514-807-9895 or 647-427-7450. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About the Phase 3 Program with Cetrorelix in BPH

The Phase 3 trial program involving more than 1,600 patients with symptomatic BPH in Canada, the United States and Europe has been completed. In addition to the efficacy trial Z-036, the program included a placebo-controlled safety and efficacy trial Z-033, the single-armed safety study Z-041, and the Thorough QT study Z-043. Results for all of these trials were disclosed recently.

About Cetrorelix

Cetrorelix pamoate is a compound that was being investigated for the treatment of BPH. Cetrorelix is part of AEterna Zentaris' luteinizing hormone-releasing hormone (LHRH) antagonist therapeutic approach.

About AEterna Zentaris Inc.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Global biostimulants market is ... at an estimated CAGR of 12.5%. In order ... products with least ecological impacts, farmers are looking ... boost crop yield more effectively & efficiently. Biostimulants ... improve the return on investments. , Leading companies ...
(Date:11/26/2014)... Theravalues Corporation est fier d,annoncer le lancement de ... Hi Europe 2014 (du 2 au 4 décembre à ... la plus biodisponible actuellement sur le marché, elle ... approuvés par les règlements européens. La ... racine de curcuma ( Curcuma longa ) qui ...
(Date:11/24/2014)... November 24, 2014 Five American ... Rashid Al Maktoum Awards for Medical Sciences", in its ... United Arab Emirates , on 15 December 2014. ... The Carter Center which won the Hamdan ... involved in numerous programs that aim to improve health ...
(Date:11/24/2014)... 23, 2014 One of the most extensive, ... and photonics is now available to high school and junior ... SPIE, the international society for optics and photonics , ... SPIE Digital Library available to high schools for ... technologies are integral to all areas of life in today’s ...
Breaking Biology Technology:2019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 32019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 4La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3Five US Winners Among Recipients of Hamdan Medical Awards 2SPIE Digital Library Now Available to High Schools, Two-Year Colleges at No or Low Cost 2
... management services for biopharmaceutical and medical device clinical trials, announced today ... how state-of-the-art image management can enhance DXA (Dual Energy X-Ray Absorptiometry) ... consider in trials using body composition measurements with DXA. , ... ...
... Value of Pharmaceuticals in a New U.S. Political ... the start of the first annual conference on ... Industry at the Loews Philadelphia Hotel. The ... insights needed to prepare for future changes in ...
... 9 Sagent Pharmaceuticals, Inc., a,privately-held specialty pharmaceutical ... injection, USP, an essential antibiotic used to treat,serious ... The 500mg single-dose vial expands ... single-dose vials and 10g pharmacy bulk package vials,launched ...
Cached Biology Technology:Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert 2ExL Pharma Presents The Pharmaceutical Managed Markets Insight & Marketing for the Pharmaceutical Industry Conference 2ExL Pharma Presents The Pharmaceutical Managed Markets Insight & Marketing for the Pharmaceutical Industry Conference 3Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial 2
(Date:11/6/2014)... is an asset for a predator. Except when that predator ... tiger beetle, relative to its size, is the fastest creature ... body lengths per second (at about five miles per hour). ... take the sprinting gold from the tiger beetle, a person ... The tiger beetle has a problem. At peak speeds, everything ...
(Date:11/5/2014)... his career to understanding the Earth,s climate and ... As deputy director and regional climatologist for the ... Institute, Redmond has more than three decades of ... climate data to the general public. , At ... on December 15-19, 2014 the American Geophysical Union ...
(Date:11/4/2014)... amount of death at the right time might actually ... research that could help in understanding animal populations, pest ... a paper in the journal Trends in Ecology ... colleagues conclude that the kind of positive population effect ... or mortality, depends on the size and developmental stage ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2When less is more: Death in moderation boosts population density in nature 2
... LAWRENCE, KAN. A new candidate gene for Specific ... directed by Mabel Rice at the University of Kansas, ... Center, and Javier Gayn of Neocodex, Seville, Spain. The ... Journal of Neurodevelopmental Disorders , was discovered by examining ...
... temperatures soar, scientists have been collecting data amid the ... These data, combined with measurements from aircraft and satellites, ... life in modern-day Athens easier during heat waves. ... months across southern Europe but the Greek capital of ...
... means Kansas State University ecologists will get more help ... opportunities for eight to 10 undergraduate students each summer ... Jumpponen, associate professors of biology, and Bruce Snyder, instructor ... National Science Foundation to help K-State continue to be ...
Cached Biology News:Researchers report gene associated with language, speech and reading disorders 2ESA helps make summer in the city more bearable 2ESA helps make summer in the city more bearable 3ESA helps make summer in the city more bearable 4
... Drosophila S2 cells are used for heterologous ... System (DES). The S2 cell line was ... (20-24 hours old) Drosophila melanogaster embryos ... at room temperature without CO2 and is easily ...
... syringe pump series combines Harvard Apparatuss best pump ... a wide range of configuration options. A lookup ... of syringes from all the major manufacturers. A ... the pertinent information from across the lab. All ...
... novel expression vectors, we in-troduced a new concept, ... at tran-scriptional level at the T7 phage promoter, ... amplifying the plasmid copy number, The main advantage ... retains practically all of the outstanding features of ...
... This CLS number is a new product ... number. If showing no availability yet, please ... or contact customer service for assistance. ... Comp Dim: surface area 21 cm 2 ...
Biology Products: